Sun Gets Two-Year Jump On Zubsolv IP With Patent-Litigation Deal
Indian Firm Was Previously Taking ANDA Fight To US Federal Circuit
Only weeks before arguments were due to be heard in Sun Pharma’s appeal against an unfavorable lower court ruling over patents shielding Orexo’s Zubsolv, the two parties have shaken hands on a settlement agreement.
